Your browser doesn't support javascript.
loading
Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia.
Gragnani, Laura; Visentini, Marcella; Fognani, Elisa; Urraro, Teresa; De Santis, Adriano; Petraccia, Luisa; Perez, Marie; Ceccotti, Giorgia; Colantuono, Stefania; Mitrevski, Milica; Stasi, Cristina; Del Padre, Martina; Monti, Monica; Gianni, Elena; Pulsoni, Alessandro; Fiorilli, Massimo; Casato, Milvia; Zignego, Anna Linda.
Afiliação
  • Gragnani L; Interdepartmental Center for Systemic Manifestations of Hepatitis Viruses (MaSVE), Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Visentini M; Department of Clinical Medicine, Sapienza University of Rome, Rome, Italy.
  • Fognani E; Interdepartmental Center for Systemic Manifestations of Hepatitis Viruses (MaSVE), Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Urraro T; Interdepartmental Center for Systemic Manifestations of Hepatitis Viruses (MaSVE), Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • De Santis A; Department of Clinical Medicine, Sapienza University of Rome, Rome, Italy.
  • Petraccia L; Interdepartmental Center for Systemic Manifestations of Hepatitis Viruses (MaSVE), Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Perez M; Istituto Dermopatico Dell'Immacolata IRCCS, Rome, Italy.
  • Ceccotti G; Interdepartmental Center for Systemic Manifestations of Hepatitis Viruses (MaSVE), Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Colantuono S; Department of Clinical Medicine, Sapienza University of Rome, Rome, Italy.
  • Mitrevski M; Department of Clinical Medicine, Sapienza University of Rome, Rome, Italy.
  • Stasi C; Interdepartmental Center for Systemic Manifestations of Hepatitis Viruses (MaSVE), Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Del Padre M; Department of Clinical Medicine, Sapienza University of Rome, Rome, Italy.
  • Monti M; Interdepartmental Center for Systemic Manifestations of Hepatitis Viruses (MaSVE), Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Gianni E; Interdepartmental Center for Systemic Manifestations of Hepatitis Viruses (MaSVE), Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Pulsoni A; Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Italy.
  • Fiorilli M; Department of Clinical Medicine, Sapienza University of Rome, Rome, Italy.
  • Casato M; Department of Clinical Medicine, Sapienza University of Rome, Rome, Italy.
  • Zignego AL; Interdepartmental Center for Systemic Manifestations of Hepatitis Viruses (MaSVE), Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. a.zignego@dmi.unifi.it.
Hepatology ; 64(5): 1473-1482, 2016 11.
Article em En | MEDLINE | ID: mdl-27483451

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Vasculite / Hepatite C Crônica / Crioglobulinemia / Sofosbuvir Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Hepatology Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Vasculite / Hepatite C Crônica / Crioglobulinemia / Sofosbuvir Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Hepatology Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Itália